000931.SZ
Beijing Centergate Technologies (Holding) Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 5.60
+10.02%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.3B | 2.4B | 2.5B | 2.3B | 2.1B |
| Cost of Revenue | 1.0B | 995.3M | 1.1B | 957.7M | 873.4M |
| Gross Profit | 1.3B | 1.4B | 1.5B | 1.3B | 1.2B |
| Operating Expenses | |||||
| R&D Expense | 103.3M | 100.7M | 106.1M | 103.5M | 121.5M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 245.2M | 247.5M | 243.7M | 219.0M | 209.9M |
| Selling & Marketing Expense | 772.2M | 902.5M | 905.2M | 805.5M | 715.5M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 1.2B | 1.3B | 1.3B | 1.2B | 1.1B |
| Cost and Expenses | 2.2B | 2.3B | 2.4B | 2.2B | 2.0B |
| Operating Income (EBIT) | 81.3M | 107.3M | 111.3M | 78.3M | (8.9M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | 79.2M | 105.6M | 121.7M | 86.6M | (8.3M) |
| Income Tax Expense | 51.7M | 44.2M | 45.2M | 21.7M | 18.5M |
| Bottom Line | |||||
| Net Income | 15.9M | 47.9M | 53.6M | 48.6M | (39.6M) |
| Earnings from Cont. Ops | 27.6M | 61.4M | 76.4M | 64.9M | (26.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 15.9M | 47.9M | 53.6M | 48.6M | (39.6M) |
| Per Share | |||||
| Basic EPS | CN¥0.02 | CN¥0.06 | CN¥0.07 | CN¥0.06 | (CN¥0.05) |
| Diluted EPS | CN¥0.02 | CN¥0.06 | CN¥0.07 | CN¥0.06 | (CN¥0.05) |
| Revenue Per Share | CN¥3.06 | CN¥3.24 | CN¥3.36 | CN¥3.02 | CN¥2.74 |
| Shares | |||||
| Basic Shares Outstanding | 752.5M | 752.9M | 752.7M | 753.1M | 752.5M |
| Diluted Shares Outstanding | 752.5M | 752.9M | 752.7M | 753.1M | 752.5M |
| Profitability Metrics | |||||
| EBITDA | — | 258.6M | 252.6M | 232.2M | 115.1M |
| D&A | — | 151.4M | 141.3M | 153.9M | 124.0M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026